KISQALI 200 MG COMP CAJ/63

Name: KISQALI

Category: ONCOLOGY

Active Substance: RIBOCYCLIB

Description: CDK4/6 inhibitor. Mechanism: Blocks cell cycle progression in G1 phase. Use: Advanced HER2-negative breast cancer.

Weight: 200MG

Presentation: 63 TABLETS

Recipe: YES

Cold Network: NO

Temperature: ROOM LESS THAN 25C

Health Registration: 343M2017 SSA

Important Notice

The information provided by Farmacias Hernandez Santé is for informational and educational purposes only.

Remember:

• This content is not a substitute for professional medical diagnosis, treatment, or prescription.
• Always consult your specialist before starting, modifying, or discontinuing any treatment.
• The proper use of medications should be supervised by a health professional.

Your well-being is our priority.